
Sign up to save your podcasts
Or


Todd Carter, PhD (CSO at Voyager Therapeutics) talks with incoming Communications Committee Chair Lynnea Olivarez about changes in the approach to developing gene therapies for CNS disorders like Huntington's disease.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
By American Society of Gene & Cell Therapy4.9
1616 ratings
Todd Carter, PhD (CSO at Voyager Therapeutics) talks with incoming Communications Committee Chair Lynnea Olivarez about changes in the approach to developing gene therapies for CNS disorders like Huntington's disease.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.

43,898 Listeners

30,666 Listeners

43,528 Listeners

25,797 Listeners

766 Listeners

145 Listeners

821 Listeners

6,435 Listeners

111,948 Listeners

56,508 Listeners

337 Listeners

16,399 Listeners

6,381 Listeners

15,950 Listeners

38 Listeners